Greater China

China Minsheng Hong Kong International Leasing is planning to raise at least $300m from its latest loan, more than the initial $200m, after receiving a good response during general syndication.

China South City Holdings executed a swift tap of its outstanding $200m 6.75% five non call three notes last Friday, adding another $150m to its coffers.

The budding Chinese Panda bond market is about to get its second Canadian issuer with the National Bank of Canada establishing an up to Rmb5bn ($750m) programme.

Three Chinese issuers went out to woo investors on Monday to get ahead of a potential boom in bond supply after announcements from the US Federal Reserve and Bank of Japan last week.

China Citic Bank International is looking to add to the recent flurry of issuance in the bank capital market, hitting the road on Monday for a Basel III additional tier one transaction.

China Merchants Securities Co has kicked off bookbuilding for a HK$11.4bn ($1.5bn) IPO, over half of which has been propped up with cornerstone investors. Meanwhile, peer-to-peer lender Lufax has hired a quartet to lead its $5bn float.

King & Wood Mallesons has hired John Baptist Chan as a partner in the corporate and securities practice in Hong Kong as the law firm looks to boost its IPO team.

Evergreen Products Group, which makes hair goods like wigs, hairpieces, braids and extensions, is seeking a listing in Hong Kong and has filed a preliminary prospectus with the regulator.

Chinese data analytics firm Gridsum Holdings has raised $82m after global investors piled in to its Nasdaq IPO.

China National Chemical Corp’s $12.7bn acquisition loan for Syngenta, which drew eight commitments during general syndication, is expected be signed with the new lenders in the next two weeks, according to bankers.

China Petrochemical Corp (Sinopec) sourced $3bn from a triple-tranche bond on Thursday, as the oil and gas giant’s credentials and frequency in the Asian G3 market paved the way for a successful trade.

Hong Kong is getting ready for a slew of $1bn-plus deals with China Resources Pharmaceutical Group preparing for its listing, as the city sees off the world’s largest IPO since 2014.